Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area.

This report describes a semi-automated method for the measurement of affinity of radiolabeled ligands interacting with cell-surface receptors on intact cancer cells. The method saves labor time and reagents compared to common manual measurements. A complete affinity measurement can be performed in one cell dish by using a target cell area and a reference area and repeatedly measure the differential activity (i.e. target activity-reference activity). The affinities obtained for different ligand-receptor interactions agreed with affinities reported in the literature.

[1]  A. Sutherland,et al.  A novel cell-based scintillation proximity assay for studying protein function and activity in vitro using membrane-soluble scintillants. , 2002, Biochemical and biophysical research communications.

[2]  T. K. Harden,et al.  The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses. , 1997, Biochemical and biophysical research communications.

[3]  R. Karlsson,et al.  Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities. , 1995, Analytical biochemistry.

[4]  G. Adams,et al.  Selection and characterization of HER2/neu-binding affibody ligands. , 2004, Protein engineering, design & selection : PEDS.

[5]  E. Blomquist,et al.  Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Peter Klein,et al.  A structure-based model for ligand binding and dimerization of EGF receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Mills,et al.  The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  P. Angelberger,et al.  DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1. , 1999, Endocrinology.

[9]  A. Bruskin,et al.  [(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent. , 2003, Cancer biotherapy & radiopharmaceuticals.